-+ 0.00%
-+ 0.00%
-+ 0.00%

CULLINAN THERAPEUTICS ADVANCES VELINOTAMIG INTO GLOBAL CLINICAL DEVELOPMENT FOR AUTOIMMUNE CYTOPENIAS FOLLOWING IND CLEARANCE BY THE U.S. FDA

Reuters·10/27/2026 11:00:03

Please log in to view news